Vaccine and control groups for Ad5hr-SIV trial.

Authors
Publication date
Publisher
Doi

    Abstract

    1<p>Prime includes injections at week 0 (oral and intranasal) and week 12 (intratracheal).</p>2<p>Boost refers to injections at week 24 and 36 (both intramuscular).</p

      Similar works

      Full text

      thumbnail-image

      Available Versions

      FigShare

      redirect
      oaioai:figshare.com:article/80580...
      Last time updated on 12/02/2018